2007年9月
Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: From six to twelve months after volume reduction
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
- ,
- ,
- ,
- 巻
- 14
- 号
- 5
- 開始ページ
- 616
- 終了ページ
- 621
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.jmig.2007.04.009
- 出版者・発行元
- ELSEVIER SCIENCE INC
STUDY OBJECTIVE: To clarify the volume change ratio of uterine myomas treated with magnetic resonance-guided focused ultrasound surgery (MRgFUS), in relation to the signal intensity of T,weighted magnetic resonance (MR) images.
DESIGN: Prospective study (Canadian Task Force classification II-3).
SETTING: Department of Gynecology, Shinsuma General Hospital, Kobe, Japan.
PATIENTS: Forty-eight myomas in 35 patients were followed up with MR images 6 months after MRgFUS, and 23 myomas in 17 patients were followed up 12 months after MRgFUS. Before treatment, the myomas were classified into 3 types on the basis of the signal intensity of T(2)-weighted MR images as follows: Type 1, low intensity; type 2, intermediate intensity; type 3, high intensity.
INTERVENTIONS: Thermal ablation therapy was performed with an MRgFUS system (ExAblate 2000).
MEASUREMENTS AND MAIN RESULTS: MRgFUS produced a greater volume reduction in type 1 and type 2 myomas than in type 3 myomas. Nonperfused areas always diminished in the period after MRgFUS; however, the volume change was affected by the volume change ratio of perfused areas inside the treated myomas.
CONCLUSION: At present, type 3 myomas should be exempted from the application of MRgFUS, because the nonperfused ratio immediately after the procedure was small compared with that in type 1 and type 2 myomas, and the subsequent volume change was unfavorable. (C) 2007 AAGL. All rights reserved.
DESIGN: Prospective study (Canadian Task Force classification II-3).
SETTING: Department of Gynecology, Shinsuma General Hospital, Kobe, Japan.
PATIENTS: Forty-eight myomas in 35 patients were followed up with MR images 6 months after MRgFUS, and 23 myomas in 17 patients were followed up 12 months after MRgFUS. Before treatment, the myomas were classified into 3 types on the basis of the signal intensity of T(2)-weighted MR images as follows: Type 1, low intensity; type 2, intermediate intensity; type 3, high intensity.
INTERVENTIONS: Thermal ablation therapy was performed with an MRgFUS system (ExAblate 2000).
MEASUREMENTS AND MAIN RESULTS: MRgFUS produced a greater volume reduction in type 1 and type 2 myomas than in type 3 myomas. Nonperfused areas always diminished in the period after MRgFUS; however, the volume change was affected by the volume change ratio of perfused areas inside the treated myomas.
CONCLUSION: At present, type 3 myomas should be exempted from the application of MRgFUS, because the nonperfused ratio immediately after the procedure was small compared with that in type 1 and type 2 myomas, and the subsequent volume change was unfavorable. (C) 2007 AAGL. All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.jmig.2007.04.009
- ISSN : 1553-4650
- Web of Science ID : WOS:000249767300017